US 6,492,165 B1 · Retrovirus isolated from humans

Abstract

The present invention comprises spumavirus isolated from humans. More specifically, the spumavirus of the present invention was isolated from humans who had exposure to nonhuman primates. Importantly, the spumavirus of the present invention or antibodies to the spumavirus can be used to detect the presence of spumavirus or antibodies in body fluids, for pathogenicity studies of related viruses, and as a vector for gene therapies. The spumavirus of the invention can also be used for treatment of conditions in humans due to the presence of rapidly dividing cells and for recombinant live virus vaccination.

Claims10

Dependent claims

A method of detecting spumavirus infection, comprising, contacting a sample with antibodies that specifically bind SFVHu-1.

Dependencies are inferred from the claim text.

Facts

Application

09/692,652Filed 19 Oct 2000 · continuation in part

Priority

12 Feb 1997

Granted

10 Dec 2002

Term ends

Not estimatedThe source records don’t support an estimate.

Classification12 codes

C07K 14/005
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from viruses
A61P 31/12
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antivirals
C12N 7/00
Viruses
C12N 15/86
For animal cells: viral vectors

Family

Application08/798,071Parent of this continuation-in-part · filed 12 Feb 1997

PCT/US98/02598Parent of this continuation-in-part · filed 12 Feb 1998

Application09/367,213Parent of this continuation-in-part

US 5,882,192 AParent of this continuation-in-part

US 5,882,912 ARelated patent

US 6,492,165 B1This patent

From the US filing history. Foreign family members aren’t listed.

Retrovirus isolated from humans

Life of this patent

Retrovirus isolated from humans

Life of this patent

Abstract

Claims10